Literature DB >> 1395063

How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?

R N Clayton1, V Ogden, J Hodgkinson, L Worswick, D A Rodin, S Dyer, T W Meade.   

Abstract

OBJECTIVE: We wished to determine the prevalence of polycystic ovaries (PCO) and relate morphological appearance to fertility.
DESIGN: We sent postal invitations to a random sample of women born in the years 1952-1969 from a list of a single Group Practice to attend for reproductive history questionnaire, examination, ultrasound scan of the ovaries and hormone measurements within 5 days of the onset of menstruation.
SUBJECTS: Of 1065 women potentially available for study, 571 (54%) replied of whom 353 (62%) agreed to participate. One hundred and ninety (18%) completed the study, 163 were deferred (57 because of current or very recent pregnancy, 106 because of inconvenience at time approached), and 18 additional women volunteered. MEASUREMENTS: Prevalence of polycystic ovaries, ovarian size and morphology, menstrual history, features of androgen excess, fertility status, serum hormone levels.
RESULTS: The prevalence of PCO was 22% (41/190). PCO and non-PCO women were similar with respect to age, body mass index, oral contraceptive pill (OCP) usage, acne, and menstrual pattern but hirsutism (Ferriman and Gallwey score > 7) was significantly (P = 0.006) more frequent among PCO women. Proven prior fertility was the same in PCO (56%) and non-PCO (64%) women and an equal proportion in each group had not yet tested their fertility. Of those women with previously proven fertility, self-perceived difficulty in conception occurred in similar proportions of women with and without PCO. Unresolved primary or secondary infertility (2.5-4%) was similar in both groups. Ovarian volume (each ovary separately) was larger in women with PCO irrespective of current OCP usage. Serum levels of oestradiol and FSH were similar in PCO and non-PCO women, but LH was distributed around a higher median in PCO women. Median testosterone and androstenedione levels were the same in PCO and non-PCO women.
CONCLUSIONS: The prevalence of polycystic ovarian morphology is high but, in this sample of women, was accompanied by minimal clinical manifestations and apparently no deleterious effects on earlier fertility. An isolated finding of polycystic ovaries may be a normal variation and should not necessarily imply altered fertility potential.

Entities:  

Mesh:

Year:  1992        PMID: 1395063     DOI: 10.1111/j.1365-2265.1992.tb02296.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  32 in total

1.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

2.  Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries undergoing in-vitro fertilisation treatment.

Authors:  Hang Wun Raymond Li; Vivian Chi Yan Lee; Estella Yee Lan Lau; William Shu Biu Yeung; Pak Chung Ho; Ernest Hung Yu Ng
Journal:  J Assist Reprod Genet       Date:  2013-12-14       Impact factor: 3.412

3.  Women and epilepsy.

Authors:  Sunila E O'Connor; Mary L Zupanc
Journal:  J Pediatr Pharmacol Ther       Date:  2009-10

4.  Complicated giant polycystic ovary mimicking tumor: MR imaging findings.

Authors:  Ibrahim Oztoprak; Hulusi Eqilmez; Bilge Oztoprak; Cesur Gümüs
Journal:  Pediatr Radiol       Date:  2006-12-20

Review 5.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

Review 6.  Central precocious puberty: current treatment options.

Authors:  Franco Antoniazzi; Giorgio Zamboni
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 7.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

8.  Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.

Authors:  S Alsamarai; J M Adams; M K Murphy; M D Post; D L Hayden; J E Hall; C K Welt
Journal:  J Clin Endocrinol Metab       Date:  2009-10-21       Impact factor: 5.958

Review 9.  The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies.

Authors:  R B Barnes
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

10.  Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome.

Authors:  Marla E Lujan; Terri G Bloski; Donna R Chizen; Denis C Lehotay; Roger A Pierson
Journal:  Hum Reprod       Date:  2009-10-24       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.